TAO Synergies TAOX
NASDAQ TAOX
$4.13 +0.12 (+2.99%)
As of: Sep 9, 2026 · 2:42 PM EDT

TAO Synergies (TAOX) Non-cash Items (2019 - 2026)

TAO Synergies' (TAOX) quarterly Non-cash Items came in at $8.4 million in Q2 2026, down 49.76% on a YoY basis from $16.8 million in Q2 2025, and up 241.88% quarter-over-quarter from -$5.9 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Non-cash Items (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Non-cash Items for 8 consecutive years, with $8.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-cash Items fell 49.76% year-over-year to $8.4 million; the trailing twelve-month figure through Jun 2026 stood at $10.4 million (down 55.49% YoY), and the FY2025 full-year result was $22.3 million, up 183.37% from the prior year.
  • Non-cash Items improved to $8.4 million in Q2 2026 per TAOX's latest filing, from -$5.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $16.8 million in Q2 2025 and bottomed at -$7.3 million in Q4 2022.
  • Historically, Non-cash Items has averaged $1.6 million across 5 years, with a median of $514006.5 in 2022.
  • The widest YoY moves for Non-cash Items: up 6352.46% in 2024, down 10273.07% in 2024.
  • Over 5 years, Non-cash Items stood at -$7.3 million in 2022, then jumped by 99.04% to -$70031.0 in 2023, then soared by 6352.46% to $4.4 million in 2024, then grew by 19.5% to $5.2 million in 2025, then jumped by 60.99% to $8.4 million in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods registered $8.4 million, -$5.9 million, and $5.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn
10 TAO Synergies 30.86 Mn 30.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.42 Mn
Mar 31, 2026 -5.94 Mn
Dec 31, 2025 5.23 Mn
Sep 30, 2025 2.73 Mn
Jun 30, 2025 16.77 Mn
Mar 31, 2025 -2.39 Mn
Dec 31, 2024 4.38 Mn
Sep 30, 2024 4.71 Mn
Jun 30, 2024 419,775.00
Mar 31, 2024 -1.62 Mn
Dec 31, 2023 -70,031.00
Sep 30, 2023 -1.94 Mn
Jun 30, 2023 2.85 Mn
Mar 31, 2023 15,972.00
Dec 31, 2022 -7.27 Mn
Sep 30, 2022 608,238.00
Jun 30, 2022 1.23 Mn
Mar 31, 2022 -207,484.00
Dec 31, 2021 2.19 Mn
Sep 30, 2021 1.85 Mn